SCHEMBL20747689

SCHEMBL20747689

CCCCCC(C)(C)C(C)OC(=O)C(C)N

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.36
SMPD1 P17405 4/20 0.33
MAPT P10636 2/20 0.33
GRIK1 P39086 2/20 0.33
GRIK2 Q13002 2/20 0.33
FDPS P14324 2/20 0.33
SLC1A2 P43004 1/20 0.33
SLC1A1 P43005 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
ATM Q13315 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
CYP4F2 P78329 1/20 0.33
CYP4A11 Q02928 1/20 0.33
TP53 P04637 1/20 0.33
FAAH O00519 1/20 0.33
SLC15A1 P46059 1/20 0.33
ALDH1A1 P00352 1/20 0.33
CES2 O00748 1/20 0.33
CA1 P00915 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20747726 0.98 LMNA (0.39) LMNASMPD1MAPTGRIK1GRIK2
SCHEMBL20747662 0.98 LMNA (0.39) LMNASMPD1MAPTGRIK1GRIK2
SCHEMBL20747630 0.95 SLC15A1 (0.34) LMNAMAPTGRIK1GRIK2FDPS
SCHEMBL20747653 0.88 LMNA (0.39) LMNA
SCHEMBL20747616 0.84 LMNA (0.38) LMNASMPD1MAPTGRIK1GRIK2
SCHEMBL20747631 0.83 LMNA (0.37) LMNASMPD1MAPTGRIK1GRIK2
SCHEMBL20747698 0.83 LMNA (0.37) LMNASMPD1MAPTGRIK1GRIK2
SCHEMBL20747771 0.81 SLC15A1 (0.34) LMNAMAPTGRIK1GRIK2FDPS
SCHEMBL20747607 0.80 GRIN2D (0.36) LMNA
SCHEMBL22851998 0.79 MAPT (0.45) LMNAMAPTMEN1KMT2AATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10208045-B2 Aza-pyridone compounds and uses thereof ALIOS BIOPHARMA, INC. (US) 2019-02-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10208045-B2 Aza-pyridone compounds and uses thereof PNPO, ITPA, PDXK LMNA 2972/4885SMPD1 2070/4885MAPT 3216/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.